| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2001 | WO2000057852A3 Methods and compositions for treating solid tumors |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | WO2000053167A3 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 02/15/2001 | WO2000051571A3 Capsule system |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000047198A3 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | WO2000002573A8 Natural composition and method for the treatment of sexual dysfunction |
| 02/15/2001 | WO2000002549A8 Composition for and method of treating neurological disorders |
| 02/15/2001 | WO1999066902A8 Injectable pharmaceutical formulations of partricin derivatives |
| 02/15/2001 | WO1999042102A8 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 02/15/2001 | DE19938387A1 Inhibition of topoisomerase I using acetyl-11-keto-beta-boswellic acid, useful as cytostatic agent, e.g. for inducing apoptosis in leukemia cells |
| 02/15/2001 | DE19938386A1 Selective inhibition of 5-lipoxygenase using acetyl-11-keto-beta-boswellic acid, useful as antiinflammatory agent free of side-effects |
| 02/15/2001 | DE19938098A1 Production of solid thioctic acid formulations comprises dry granulation or direct tabletting of active agent with adjuvants |
| 02/15/2001 | DE19937496A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents, e.g. for treating viral infections, tumors, inflammation or autoimmune disease |
| 02/15/2001 | DE19937350A1 Treating C1q-esterase inhibitor protein synthesis disorders, especially angioneurotic edema, using tibolone, without androgenic and virilization side-effects |
| 02/15/2001 | DE19936997A1 Verfahren zur Nutzung von Dendrimeren als Multiplikatoren zur Verabreichung von Photosensibilisatoren Procedures for the use of dendrimers as multipliers for administration of photosensitizers |
| 02/15/2001 | DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin |
| 02/15/2001 | DE19936719A1 Substituierte 1,5-Dihydropyrrol-2-on-Derivate Substituted 1,5-dihydropyrrol-2-one derivatives |
| 02/15/2001 | DE19936672A1 Reinforcing epithelial barrier of vaginal mucosa for prophylaxis of perinatally, sexually or other vaginally transferred infections comprises topical application of retinoic acid or its ester or retinol ester |
| 02/15/2001 | DE19936521A1 Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate Substituted pyrrolidine-2,3,4-trione-3-oxime Derivatives |
| 02/15/2001 | CA2403910A1 Headache and colic relief composition with asafetida and method of use thereof |
| 02/15/2001 | CA2382759A1 Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient |
| 02/15/2001 | CA2381919A1 Novel tryptase inhibitors |
| 02/15/2001 | CA2381910A1 Novel vitamin d analogues |
| 02/15/2001 | CA2381846A1 Potentiation of inclusion complex formation of cyclodextrin derivatives |
| 02/15/2001 | CA2381699A1 Novel methods of diagnosis of angiogenesis compostions and methods of screening for angiogenesis modulators |
| 02/15/2001 | CA2381621A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381290A1 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381260A1 Novel 1,4-benzodiazepine compounds and derivatives thereof |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2381033A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2380981A1 Fluorene derivatives |
| 02/15/2001 | CA2380973A1 Substituted pyrrolidine-2-3,4-trione 3-oxime derivatives which are active as nmda receptor antagonists |
| 02/15/2001 | CA2380759A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 02/15/2001 | CA2380678A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | CA2380647A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | CA2380312A1 Formulations for parenteral use of estramustine phosphate and albumin |
| 02/15/2001 | CA2379977A1 Novel integrin receptor antagonists |
| 02/15/2001 | CA2379608A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | CA2379335A1 Crystals of the sodium salt of pravastatin |
| 02/15/2001 | CA2379322A1 Torsemide polymorphs |
| 02/15/2001 | CA2379302A1 Therapeutic agent for diabetes |
| 02/15/2001 | CA2379087A1 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | CA2379052A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 02/15/2001 | CA2379047A1 Nitroxy derivatives of (r) and (s)-carnitine |
| 02/15/2001 | CA2378990A1 1,4-substituted 4,4-diaryl cyclohexanes |
| 02/15/2001 | CA2378984A1 Antiviral therapy use of p-glycoprotein modulators |
| 02/15/2001 | CA2378955A1 Use of gaba agonists for treatment of spastic disorders, convulsions, and epilepsy |
| 02/15/2001 | CA2378620A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 02/15/2001 | CA2378572A1 Intravaginal clindamycin ovule composition |
| 02/15/2001 | CA2378499A1 Cyclic amine ccr3 antagonists |
| 02/15/2001 | CA2378486A1 Osteogenesis promoter sustained-release paste |
| 02/15/2001 | CA2378482A1 Use of n-methyl bases of ethanolamine for prevention of cell death induced by oxidative stress |
| 02/15/2001 | CA2378481A1 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | CA2378445A1 Use of anti-muscarinic agents for treating skin disorders |
| 02/15/2001 | CA2378401A1 Implantable active ingredient depot |
| 02/15/2001 | CA2378315A1 Neuropathy therapeutic agent |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | CA2378292A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | CA2378267A1 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 02/15/2001 | CA2378257A1 Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight |
| 02/15/2001 | CA2378241A1 Benzanilides as potassium channel openers |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/15/2001 | CA2348959A1 Methods of cytoprotection using an enantiomer of estrogen of ischemic damage |
| 02/15/2001 | CA2346291A1 Controlled release from copolymers of acrylic or methacrylic acid/l-dopa, acrylic or methacrylic acid/l-.alpha.-methyl dopa, acrylic or methacrylic acid/carbidopa and their combinations |
| 02/14/2001 | EP1076091A1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/14/2001 | EP1076057A1 Febrifugine and isofebrifugine and processes for the preparation of both |
| 02/14/2001 | EP1076055A1 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 02/14/2001 | EP1076053A1 3-arylphenyl sulfide derivatives and insecticides and miticides |
| 02/14/2001 | EP1075839A1 Plasma expander, blood diluent and cryoprotector produced using amylopectin-potato starch |
| 02/14/2001 | EP1075837A2 Process for the preparation of aqueous formulations for ophthalmic use |
| 02/14/2001 | EP1075836A2 Skin care of food composition containing N-acetyl-glucosamine |
| 02/14/2001 | EP1075833A1 Barrier cream |
| 02/14/2001 | EP1075535A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 02/14/2001 | EP1075508A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 02/14/2001 | EP1075486A1 Method of treating bladder and lower urinary tract syndromes |
| 02/14/2001 | EP1075484A1 Novel anthracycline derivatives and their preparation |
| 02/14/2001 | EP1075483A2 Hygromycin a derivatives |
| 02/14/2001 | EP1075481A1 Monomeric, oligomeric and polymeric knoevenagel condensation products |
| 02/14/2001 | EP1075478A1 Phenylurea and phenylthio urea derivatives |
| 02/14/2001 | EP1075477A1 Novel n-oxides |
| 02/14/2001 | EP1075476A1 Novel benzimidazoles and benzoxazoles |
| 02/14/2001 | EP1075475A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 02/14/2001 | EP1075474A1 Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 02/14/2001 | EP1075473A1 Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 02/14/2001 | EP1075472A1 Prodrugs of benzofuranylmethyl carbamate nk 1? antagonists |
| 02/14/2001 | EP1075471A1 Indolyl derivatives as serotonergic agents |
| 02/14/2001 | EP1075467A1 Pyrazole derivatives as p-38 map kinase inhibitors |
| 02/14/2001 | EP1075466A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/14/2001 | EP1075278A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D 2?) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING $g(b) 2?-ADRENORECEPTOR AGONIST ACTIVITY |
| 02/14/2001 | EP1075277A2 Methods for detecting and inhibiting angiogenesis |
| 02/14/2001 | EP1075272A1 Methods for treating diabetes by inhibiting gdf-8 |
| 02/14/2001 | EP1075268A1 Use of a fluoride ion vector for preparing a medicine for preventing or treating diseases associated with helicobacter pylori |